TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
RLYB

Rallybio Corp

Healthcare · Biotechnology

15.80$ +0.9% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Rallybio Corp (RLYB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 29.2% of the shares are freely tradable; institutional investors hold 98.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 98.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 29.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 6Mio.

Largest Shareholders

Institutions

Institutions RLYB
Name Stake (%) Shares Change (%) Date
ADAR1 Capital Management LLC 17.44 926,352 +4,411.1 06/30/2026
FMR Inc 14.96 794,720 +0.2 06/30/2026
Viking Global Investors LP 9.87 524,347 +0.0 06/30/2026
TPG GP A, LLC 7.13 378,551 +0.0 06/30/2026
Nantahala Capital Management, LLC 7.09 376,844 +25.3 06/30/2026
Pivotal bioVenture Partners Investment Advisor LLC 5.66 300,579 +0.0 06/30/2026
Renaissance Technologies Corp 3.76 199,907 +27.7 06/30/2026
Vanguard Capital Management, LLC 3.25 172,497 +54.0 06/30/2026

Funds

Funds RLYB
Name Stake (%) Shares Change (%) Date
Fidelity Growth Company Fund 3.90 207,412 +0.0 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.53 134,620 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings RLYB
Person Role Shares Value As of Type
Uden Stephen Chief Executive Officer 148,864 2,352,051 $ Oct 27, 2026 direct
Mackay Martin Director 125,032 1,975,506 $ Nov 4, 2026 direct
Lieber Jonathan I Chief Financial Officer 44,139 697,396 $ Nov 2, 2026 direct
Hunt Ronald Director 29,125 460,175 $ Nov 4, 2026 direct
Hopfner Robert Lorne Director 14,820 234,156 $ Oct 12, 2026 direct
Liu Hui Director 12,044 190,295 $ Sep 24, 2026 direct
Boudreau Helen M Director 8,604 135,943 $ Oct 16, 2026 direct
Soteropoulos Paula Director 6,544 103,395 $ Oct 16, 2026 direct
Chung Wendy Director 5,624 88,859 $ Oct 26, 2026 direct
Nash Christine A Director 3,562 56,280 $ Oct 28, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Nov 4, 2026 Mackay Martin Director Other 18,055 4.45 80,345
Nov 4, 2026 Mackay Martin Director Other 3,562 2.38 8,478
Nov 4, 2026 Mackay Martin Director Other 11,607 7.60 88,213
Nov 4, 2026 Hunt Ronald Director Other 14,305 4.45 63,657
Nov 2, 2026 Lieber Jonathan I Chief Financial Officer Other 7,124 14.88 106,005
Oct 29, 2026 Lieber Jonathan I Chief Financial Officer Other 13,589 6.08 82,621
Oct 29, 2026 Lieber Jonathan I Chief Financial Officer Other 7,875 14.88 117,180
Oct 29, 2026 Hunt Ronald Director Other 2,062 15.28 31,507
Oct 29, 2026 Hunt Ronald Director Other 9,196 7.60 69,890
Oct 29, 2026 Hunt Ronald Director Other 3,562 2.38 8,478
Oct 28, 2026 Nash Christine A Director Other 3,562 2.38 8,478
Oct 27, 2026 Uden Stephen Chief Executive Officer Other 33,244 6.08 202,124
Oct 27, 2026 Lieber Jonathan I Chief Financial Officer Sell 599 16.04 9,608
Oct 26, 2026 Lieber Jonathan I Chief Financial Officer Other 2,500 0.00 –
Oct 26, 2026 Chung Wendy Director Other 2,062 15.28 31,507
Oct 16, 2026 Soteropoulos Paula Director Other 3,562 2.38 8,478
Oct 16, 2026 Boudreau Helen M Director Other 2,062 15.28 31,507
Oct 12, 2026 Hopfner Robert Lorne Director Other 2,062 15.28 31,507
Oct 12, 2026 Hopfner Robert Lorne Director Other 3,562 2.38 8,478
Oct 12, 2026 Hopfner Robert Lorne Director Other 9,196 7.60 69,890
Oct 9, 2026 Lieber Jonathan I Chief Financial Officer Other 3,910 6.08 23,773
Oct 6, 2026 Uden Stephen Chief Executive Officer Other 22,456 6.08 136,532
Sep 29, 2026 Lieber Jonathan I Chief Financial Officer Other 5,000 6.08 30,400
Sep 24, 2026 Liu Hui Director Other 8,482 7.60 64,463
Sep 24, 2026 Liu Hui Director Other 3,562 2.38 8,478
Sep 16, 2026 Chung Wendy Director Other 3,562 2.38 8,478

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?